The Food and Drug Administration (FDA) carried out an inspection for foodborne biological hazards at Enzyme Development Corporation in Scranton on March 18, based on information published on the FDA’s website.
The inspection’s final report found that Enzyme Development Corporation did not need to implement any corrective actions regarding its management operations.
The FDA performs routine inspections of facilities nationwide to assess workplace and product compliance with FDA regulations intended to protect public health. The results of these inspections are made available to the public.
As described on its website, the FDA is a federal agency tasked primarily with overseeing the production and distribution of human and animal drugs, biological products, medical devices and tobacco products to ensure safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
